Enovix director awarded 29,104 RSUs

MCCRANIE J DANIEL reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

MCCRANIE J DANIEL reported acquisition or exercise transactions in this Form 4 filing.

Enovix Corp director J. Daniel McCranie received an equity grant in the form of restricted stock units (RSUs). On June 11, 2026 he was awarded 29,104 RSUs of Enovix common stock at no cash cost as part of his compensation. Each RSU represents a contingent right to receive one share of common stock, with 25% vesting on each of September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholders meeting, subject to continued service. Following this grant, he held 69,982 shares in total, including 48,379 shares issuable upon settlement of RSUs.

Insider Trade Summary

Grant/Award: 29,104 shares

Grant/Award 1 txn

Insider MCCRANIE J DANIEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,104	$0.00	$0.00

Holdings After Transaction: Common Stock — 69,982 shares (Direct)

Footnotes (2)

1. F1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
2. F2. Includes 48,379 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Key Figures

RSUs granted: 29,104 RSUs Price per share: $0.0000 per share Total holdings after grant: 69,982 shares +3 more

6 metrics

RSUs granted 29,104 RSUs Equity award granted June 11, 2026

Price per share $0.0000 per share Grant price for RSU award

Total holdings after grant 69,982 shares Shares beneficially owned after June 11, 2026 grant

RSUs included in holdings 48,379 shares Shares issuable upon settlement of RSUs included in total holdings

First vesting date September 11, 2026 25% of RSUs vest, subject to continuous service

Final vesting timeframe June 11, 2027 or 2027 meeting Last 25% vests on earlier of those dates

Key Terms

restricted stock units ("RSUs"), contingent right, vesting, beneficially owned

4 terms

restricted stock units ("RSUs") financial

"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock."

vesting financial

"25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

beneficially owned financial

"Includes 48,379 shares issuable upon the settlement of RSUs granted to the Reporting Person."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enovix (ENVX) director J. Daniel McCranie report?

Enovix director J. Daniel McCranie reported receiving 29,104 restricted stock units (RSUs) on June 11, 2026. These RSUs are a stock-based compensation award and do not reflect an open-market purchase or sale of Enovix common shares.

How many Enovix (ENVX) shares does J. Daniel McCranie hold after this Form 4?

After the reported grant, J. Daniel McCranie holds 69,982 Enovix shares in total. This figure includes 48,379 shares issuable upon settlement of RSUs previously granted, showing his overall equity exposure to the company.

What are the vesting terms of the new Enovix (ENVX) RSU grant to McCranie?

The 29,104 RSUs vest in four equal 25% installments. Vesting dates are September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholders meeting, subject to continuous service.

Did J. Daniel McCranie buy or sell Enovix (ENVX) stock in the market?

The Form 4 shows a grant of RSUs, not a market trade. Code “A” indicates a grant, award, or other acquisition, so no open-market buying or selling of Enovix common stock occurred in this reported transaction.

What does each Enovix (ENVX) RSU granted to McCranie represent?

Each RSU represents a contingent right to receive one share of Enovix common stock. Shares are only delivered if vesting conditions are met, including McCranie’s continuous service through the applicable vesting dates described in the award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 09:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCRANIE J DANIEL

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W. WARREN AVENUE

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		29,104(1)	A	$0	69,982(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.

2. Includes 48,379 shares issuable upon the settlement of RSUs granted to the Reporting Person.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for John Daniel McCranie	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)